Hong Kong IPOs

Healthcare

• Sino Medical Sciences Technology
• Sichuan Neautus Traditional Chinese Medicine (representing GF Capital and ABCI)
• Distinct Healthcare
• Ribo Life Science (representing CICC and Citigroup)
• BenQ BM Holding
• Medcaptain Medical Technology (representing Morgan Stanley and Huatai)
• Hangzhou Diagens Biotechnology (representing Huatai)
• Sainte Nutritional (representing CITIC Securities)*
• Dermavon Holdings (representing Huatai)*
• Jiangxi Rimag Group (representing CITIC Securities)*
• Beijing Airdoc Technology (representing UBS and CITIC Securities)*
• Apollomics (representing Morgan Stanley, BofA and China Renaissance)*
• Yunnan Walvax Biotechnology (representing CITIC Securities, Haitong, Jefferies and CICC)*
• JOINN Laboratories (representing CITIC Securities)*
• Hepalink Pharmaceutical (representing Goldman Sachs and Morgan Stanley)*
• TOT Biopharm*
• New Century Healthcare*
• Phoenix Healthcare (representing Goldman Sachs and Deutsche Bank)*

Consumer and TMT

• Roborock Technology (representing JP Morgan and CITIC Securities)
• Alkaidsemi (Shanghai) Technologies
• JoulWatt Technology*
• Hangzhou Tongshifu Cultural and Creative (representing CMBI)*
• Hebei Haiwei Electronic New Material (representing CICC)*
• Zhou Liu Fu Jewellery (representing CICC and CSCI)*
• China Tobacco International (HK)*
• CSMall Group*
• China ZhongDi Dairy (representing Morgan Stanley)*
• Ozner Water (representing Goldman Sachs and Standard Chartered)*

Manufacturing and Financial Services

• CNGR Advanced Material (representing Morgan Stanley and Huatai)
• Fuyao Glass (representing UBS and China Merchants Securities)*
• China Reinsurance (Group) (representing UBS, CICC and HSBC)*
• Shengjing Bank*

Other Capital Markets and M&A Transactions

• Jiangxi Rimag Group in its placing of H shares*
• China Mobile in its:
• investment as cornerstone investor in the Hong Kong IPO of China International Capital Corporation*
• placing of shares in China International Capital Corporation*
• Mengniu Dairy in its:
• investment as cornerstone investor in the HK IPO of YuanShengTai Dairy Farm*
• placement of shares of Yashili International to Temasek, Hopu and other investors*
• acquisition of a 16.7% stake in and subsequent mandatory cash offer for China Modern Dairy*
• takeover of Yashili International by way of voluntary general offer*
• issuance of exchangeable bonds*
• issuance of senior notes*
• Yashili International in its:
• acquisition of Dumex Baby Food from Danone SA*
• acquisition of Oushi Mengniu Dairy Products from Mengniu Dairy*
• disposal of Yashili (Zhengzhou) to a joint venture company established by Mengniu Dairy and The WhiteWave Foods Company*
• C.banner International in its:
• acquisition of Hamleys Global*
• issuance of convertible bonds and notes to CCB International*
• Bank of Chongqing in its placing of H shares*
• G-Resources in its rights issue*
• Nomura as financial adviser to Yue Xiu in its takeover of Chong Hing Bank Limited*
• Pou Chen Corporation in its proposed privatization of HKSE-listed Pou Sheng International by way of a scheme of arrangement*
• Taiwan Cement Corporation and TCC International Limited in their privatization of TCC International Holdings by way of scheme of arrangement*
• Suning Commerce Group in its acquisition of Allyes Information Technology from Silver Lake*

Public Companies Compliance Matters

• Advising Hong Kong-listed companies including Rimag Group, China Tobacco International (HK), China Telecom, China Mobile, Mengniu Dairy, Yashili International, Bank of Chongqing, and Clear Media Limited on securities law related compliance matters*

* Work above performed prior to joining O’Melveny